Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Skip to main content

Health Care

The Q2 2024 earnings season is drawing to a close with 93% of S&P 500 companies having reported results as we go to press. Nearly 80% (60%) of companies have topped earnings (sales) expectations in Q2, according to Factset. Excluding Materials and Real…
According to BCA Research’s US Political Strategy service, in the final months of an election cycle, equities underperform relative to non-election years. This extends further into Q1 of the following year due to uncertainty. Once the election results are…

Favor Health Care and Utilities for defensive positioning amid economic slowdown and volatility as the presidential election approaches. A Republican Sweep favors Real Estate and Materials, while the second most likely outcome, Democrat gridlock, favors Health Care, and Information Technology.

We continue to expect a recession by early 2025 but assign non-trivial odds to growth surprising to the upside until then. Our Global Investment Strategy team thus recommends investors adopt a barbell equity strategy as a hedge for the second half of 2024,…
The Case For S&P 500 Healthcare …

Generative AI-related rally resumed in May. Much of the recent market gains are down to excess liquidity that was begotten by the massive pandemic stimulus, creating a dichotomy between multiple economic challenges and exuberant markets. The Fed is unlikely to step in to prevent the bubble as it is currently more worried about the near-term downside for growth than financial stability.

We recommend overweight in Pharma over a tactical and strategic investment horizon, as challenges, that have recently hampered the industry group’s performance, are dissipating. Likely election outcomes are positive for the industry, while major trends like generative AI applied to drug development and an aging population are long-term tailwinds.

Q1 Earnings and sales growth were strong, but the devil is in the details: Without the Magnificent Five, earnings growth for the index would have been negative. On a positive note, margins have stabilized, and earnings growth is expected to broaden into yearend. Companies are optimistic about the economy. Development of AI applications is in full swing, but few companies are monetizing them yet. Consumer spending is strong but is slowing. We reiterate our underweight of consumer sectors, and overweight of Software and Services as the “don’t fight AI” adage holds.

In this week’s report, we defend four out-of-consensus claims. Claim #1: Underlying inflation in the US is not reaccelerating. Claim #2: The US labor market is set to weaken abruptly. Claim #3: The S&P 500 will drop to 3700 in 2025. Claim #4: Japan is not in danger of a currency crisis.

Health care stocks have underperformed the US broad market by over 20% since the beginning of 2023. Indeed, vaccination campaigns during the pandemic years had initially boosted health care companies’ earnings. However, this tailwind eventually faded.…